HCA Healthcare, Inc. (NYSE:HCA) Receives $359.89 Consensus Target Price from Analysts

HCA Healthcare, Inc. (NYSE:HCA) has received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $359.89.

A number of analysts have recently issued reports on HCA shares. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Wells Fargo & Company boosted their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Barclays raised their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. CreativeOne Wealth LLC purchased a new position in shares of HCA Healthcare in the first quarter worth approximately $231,000. New Mexico Educational Retirement Board grew its holdings in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after buying an additional 3,200 shares in the last quarter. KBC Group NV lifted its stake in HCA Healthcare by 60.6% in the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after acquiring an additional 138,146 shares in the last quarter. Kingswood Wealth Advisors LLC purchased a new position in HCA Healthcare during the 1st quarter valued at about $566,000. Finally, Teachers Retirement System of The State of Kentucky boosted its holdings in shares of HCA Healthcare by 15.6% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after purchasing an additional 26,919 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.2 %

NYSE HCA opened at $405.45 on Friday. HCA Healthcare has a one year low of $215.96 and a one year high of $409.42. The company’s 50 day moving average price is $381.85 and its 200 day moving average price is $344.10. The firm has a market capitalization of $106.19 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period last year, the company posted $4.29 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, sell-side analysts predict that HCA Healthcare will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.